Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer.
Saved in:
| Title: | Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer. |
|---|---|
| Authors: | Grady CB; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Hwang WT; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Reuss JE; Department of Medicine, Georgetown University, Washington, DC, USA., Iams W; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Cass A; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Liu G; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Patel D; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Liu SV; Department of Medicine, Georgetown University, Washington, DC, USA., Montenegro GLB; Department of Medicine, Georgetown University, Washington, DC, USA., Patil T; Division of Medical Oncology, Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado, USA., Nieva JJ; Department of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California, USA., Herrmann A; Department of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California, USA., Marrone KA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lam VK; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Schwartzman W; Department of Internal Medicine, Harold C Simmons Comprehensive Cancer Center, UT Southwestern, Dallas, Texas, USA., Dowell J; Department of Internal Medicine, Harold C Simmons Comprehensive Cancer Center, UT Southwestern, Dallas, Texas, USA., Villaruz LC; Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Miller KL; Department of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA., Weiss J; Department of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA., Sun F; Department of Medicine, UCSF School of Medicine, University of California San Francisco, San Francisco, California, USA., Velcheti V; Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA., Camidge DR; Division of Medical Oncology, Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado, USA., Aggarwal C; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Sun L; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Marmarelis ME; Department of Medicine, Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. |
| Source: | Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Dec; Vol. 33 (12), pp. e70049. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1099-1557 |
|---|---|
| DOI: | 10.1002/pds.70049 |
